Last updated on March 2015

Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Human Papilloma Virus
  • Age: Between 10 - 11 Years
  • Gender: Male or Female
  • Other:
    All those children whose parents accept their participation in the study.

You may not be eligible for this study if the following are true:

  • Fever,
    previous vaccination against HPV,
    allergy to vaccine components,
    thrombocytopenia,
    immunosuppression,
    diarrhea,
    vomiting,
    dyscrasia,
    administration of another anti-viral vaccine in the previous 15 days.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.